Latest Breaking News On - Hartline investment corp - Page 7 : comparemela.com

Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) Director Gordon M. Binder purchased 50,000 shares of the firm’s stock in a transaction that occurred on Wednesday, May 15th. The shares were bought at an average cost of $6.78 per share, for a total transaction of $339,000.00. Following the completion of the acquisition, the director now directly […]

Gordonm binderPiper sandlerCantor fitzgeraldHartline investment corpVanguard group incAdvisor groupCapstone investment advisorsHumacyte incGet free reportDirector gordonFunds managementInvestment advisorsHumacyte daily